Harisons Pharmaceuticals Limited
About Harisons Pharmaceuticals Limited
Data last updated:
Harisons Pharmaceuticals Limited is a public limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 June 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24239CH1996PLC018334. Its GSTIN is 04AAACH7025F1Z2 (Chandigarh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Deepak Bajaj and Nanu Bajaj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 62 Phase – Iiindustrial Area Chandigarh, Chandigarh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.48 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹60,736 (net margin 0.4%) and EBITDA of ₹91,083 (EBITDA margin 0.6%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 9% over five years.
As per MCA filings, the company has open charges of ₹1.65 Cr and satisfied charges of ₹70 Lakh on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address62 Phase – Iiindustrial Area Chandigarh, Chandigarh, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Harisons Pharmaceuticals Limited
The main business activity of Harisons Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Harisons Pharmaceuticals Limited FY 2025 filings available
Harisons Pharmaceuticals Limited reported revenue of ₹1.48 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Harisons Pharmaceuticals Limited
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 7% fall in the latest year. EBITDA rose 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Harisons Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹91,083 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹60,736 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Harisons Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Harisons Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Harisons Pharmaceuticals Limited
Harisons Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Bajaj | Director | 01 Jul 2002 | 24 Years 3 Months | Current |
| Nanu Bajaj | Director | 01 Jul 2002 | 24 Years 3 Months | Current |
| Dinesh Rawat | Director | 08 Nov 2012 | 13 Years 11 Months | Current |
Peer Comparison of Harisons Pharmaceuticals Limited
Harisons Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Unihelix Biotech Private Limited | ₹1.49 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Kolkata, West Bengal, India |
| Chemixl Intermediates Private Limited | ₹1.49 Cr (FY 2025) | •••• | •••• | -41.0% | •••• | Umargam, Gujarat, India |
| Native Drugs Private Limited | ₹1.49 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Amritsar, Punjab, India |
| Actiff Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2019) | •••• | •••• | 31.0% | •••• | Nallasopara West, Maharashtra, India |
| Marvel Medilinks Private Limited | ₹1.48 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Punjab, India |
| Harisons Pharmaceuticals Limited this company | ₹1.48 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Chandigarh, India |
| Florian Lifescience Private Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Patna, Bihar, India |
| Simpha Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2016) | •••• | •••• | 182.0% | •••• | Bangalore, Karnataka, India |
| Hawitt Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Rajasthan, India |
| Cure World Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Panchkula, Haryana, India |
| Peptas Pharma Private Limited | ₹1.48 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Harisons Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Harisons Pharmaceuticals Limited
Harisons Pharmaceuticals Limited is audited by SHAMSHER & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHAMSHER & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Harisons Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Harisons Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Mar 2011 | Pumjab & Sind Bank | ₹1.25 Cr | Open |
| 16 Aug 2005 | State Bank of India | ₹40 Lakh | Open |
| 29 Jul 2009 | Indian Overseas Bank | ₹70 Lakh | Satisfied |
Total charge records: 3 View all charges
Legal Cases of Harisons Pharmaceuticals Limited
Harisons Pharmaceuticals Limited has 4 court cases on record: 2 filed by Harisons Pharmaceuticals, 2 filed against it. All cases are disposed. Status as checked between 01 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
| District courts | 2 | 2 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Punjab and Haryana | Writ petition | Filed by the company against an individual | Disposed |
| High Court of Punjab and Haryana | Writ petition | Filed by the company against an individual | Disposed |
| District court, Sirsa, Haryana | Cheque dishonour complaint | Filed against the company by an individual | Disposed |
| District court, Jalandhar, Punjab | Commercial suit | Filed against the company by an individual | Disposed |
Full case history
All 4 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Harisons Pharmaceuticals Limited
Employment history and EPFO contributions of people linked to Harisons Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Harisons Pharmaceuticals Limited
Harisons Pharmaceuticals Limited has 4 board changes on record since 2002: 3 appointments and 1 cessation. The latest: Balwant Rai Bajaj ceased to be Director on 08 Nov 2012.
Credit Ratings, Litigation & Regulatory Alerts for Harisons Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Harisons Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Harisons Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Harisons Pharmaceuticals Limited
Harisons Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAACH7025F1Z2 | Chandigarh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Harisons Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harisons Pharmaceuticals Limited
Harisons Pharmaceuticals is an active public limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 June 1996 (30+ years old) and is registered under CIN U24239CH1996PLC018334.
Harisons Pharmaceuticals reported revenue of ₹1.48 Cr for FY 2025 (down 7% YoY).
Harisons Pharmaceuticals has 3 current directors:
- Deepak Bajaj - Director
- Nanu Bajaj - Director
- Dinesh Rawat - Director
Harisons Pharmaceuticals reported a net profit of ₹60,736 (net margin 0.4%) and EBITDA of ₹91,083 (EBITDA margin 0.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Harisons Pharmaceuticals is -3% over three years and -9% over five years. In the latest year (FY 2025) revenue fell 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Harisons Pharmaceuticals is 04AAACH7025F1Z2, registered in Chandigarh.
The CIN (Corporate Identification Number) of Harisons Pharmaceuticals is U24239CH1996PLC018334. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Harisons Pharmaceuticals has 4 court cases on record: 2 filed by the company and 2 filed against it. Most are in the high courts.
Harisons Pharmaceuticals was incorporated on 13 June 1996, making it 30+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Harisons Pharmaceuticals by revenue are Unihelix Biotech Private Limited, Chemixl Intermediates Private Limited, Native Drugs Private Limited, Actiff Pharmaceuticals Private Limited, Marvel Medilinks Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Balwant Rai Bajaj ceased to be Director on 08 Nov 2012. Dinesh Rawat was appointed as Director on 08 Nov 2012. Deepak Bajaj was appointed as Director on 01 Jul 2002. Harisons Pharmaceuticals has 4 board changes on record in total.